Advanced Filters
noise

human-papilloma-virus Clinical Trials

A listing of human-papilloma-virus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 211 clinical trials
Y Yong Li

Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy

Cervical cancer CC is the most common malignant tumor in the female reproductive system, seriously endangering women's health and life, and is one of the leading causes of death for women worldwide.Globally, HPV causes about 85% of cervical cancers and about 60% of oropharyngeal cancers, causing more than 500,000 cancers …

18 - 75 years of age Female Phase N/A
V Valerie Burešová, Mgr.

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

This study defines the prevalence of oral infection with high-risk human papillomaviruses (hrHPV) in individuals over 40 years of age in the Czech Republic. It also establishes an effective methodology for oropharyngeal carcinoma screening and optimization of screening and testing procedures.

40 years of age All Phase N/A
H Hugo Kavunga

Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)

This study is a multi-country and multi-site project to estimate the point-prevalence of high-risk (HR) HPV genotype infections among representative samples of girls and women aged 9-50 years, and among specific sub-populations to estimate the incidence of persistent HPV infection among sexually active young women. The data to fulfill the …

9 - 50 years of age Female Phase N/A
J Julie HT Dang, PhD

HPV Ends Here: Increasing Uptake of the HPV Vaccine

Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.

10 - 12 years of age All Phase N/A
L Liuing Gong, MS

Effectiveness of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination in China

This interventional study targets female students in junior middle school. It goal is to evaluate the effectiveness of a vaccine chatbot on HPV vaccine awareness and vaccination. The main questions it aims to answer are: How will the novel digital tool, a vaccine chatbot, impact eligible parents' awareness and knowledge …

10 - 16 years of age Female Phase N/A
C Cindy Shekailo

The STOP-HPV Scale Up Study

Human papillomavirus (HPV) causes 35,900 US cancer cases per year, 4,000 deaths, and $4 billion in can In this study, the investigators will conduct a 3-arm clustered randomized controlled trial (RCT) in an estimated 72 practices from up to 8 health systems to evaluate the effectiveness and cost effectiveness of …

9 - 17 years of age All Phase N/A
S Sarah BOUEE

Impact of Human Papillomavirus Carriage on IVF/ICSI Results (HPV AMP)

The prevalence of the papilloma virus in the general population is 12%. This virus is known to impair male fertility but its impact on female infertility remains uncertain. This is a public health problem since there is a vaccination protocol. Demonstrating the impact of the human papillomavirus on fertility would …

25 - 38 years of age Female Phase N/A
K Khamsook Phommavongsa

Integration to Improve Adolescent Health and HPV Vaccination in Laos

The goal of this study is to find out if adding HPV vaccination to adolescent health services works to increase HPV vaccine uptake in 10-13-year-old girls in Laos. The study will also look at the effects of adding HPV vaccination on the use of other health services in 10-13-year-old boys …

10 - 13 years of age All Phase N/A

Anal Follow-up of Patients With a Gynecological History of High-grade Lesion and More Induced HPV

Human Papillomavirus (HPV) infection is the most common sexually transmitted infection in the world. It is currently estimated that 4.5% of all cancers worldwide are attributable to HPV, representing 630,000 new cases per year. HPV is responsible for more than 98% of pre-cancerous and cancerous lesions of the cervix and …

18 years of age Female Phase N/A
S Sindy Gonzalez

Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine

The educational intervention to be delivered by the PN(Patient Navigator) consists of "toolkit education materials" developed by the National Cancer Institute (NCI) and a small media intervention (i.e., video) that our research team has developed. The NCI-produced toolkit education materials consist of Power Point presentations, flyers, and posters that contain …

18 years of age All Phase N/A

Simplify language using AI